Translational Oncology Training Program
转化肿瘤学培训计划
基本信息
- 批准号:10599892
- 负责人:
- 金额:$ 32.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Summary
Cancer is the second leading cause of death in the US, and many challenges still remain to discover novel and
more effective approaches to cure this devastating disease, which requires strong effort in translating basic
science knowledge into clinics. To accomplish this goal and further promote translational cancer research, it is
imperative to establish a sustainable program to train and educate the next generation of scientists and
clinicians, who must have broad knowledge and the ability to communicate and work with colleagues in both
fields. The goal of the Translational Oncology Training program (TOTP) is to ensure that the next
generation of cancer researchers are equipped with the tools and knowledge that will enable them to
bring bench-top discoveries into clinical trials and vice versa. The fellows and students in this program
will receive unique training in four different but highly integrated themes: Preclinical Modeling (PCM); Cancer
Image Guidance (CIG); Cancer Bio-Validation (CBV); and Clinical Translation (CLT). PCM focuses on analysis
of pathways and signaling involved in tumor progression using various preclinical models in order to identify
potential therapeutic targets and biomarkers. CIG provides training in state of the art image-guided diagnostic
approaches and nanotechnology-based drug delivery systems. Trainees in CBV will learn up-to-date
bioinformatics skills in multi-omics setting in order to study and analyze large cohort patient database.
Preceptors in CLT have ample experiences in clinical trials and they provide guidance on how to translate
basic knowledge into clinical trials. Trainees will rotate through three out of four themes during the first year
while taking didactic lectures from all four themes. They will also assemble a mentoring team consisting of both
Ph.D and MD faculty. The majority of preceptors of this T32 program are in the Hematology/Oncology and
Cancer Biology departments. This structure merges strong clinical and basic science entities in the Wake
Forest Baptist Comprehensive Cancer Center (WFBCCC). However, this training program is multidisciplinary
and in all, preceptors come from 11 different departments. The program is unique with many innovative training
tools: (i) highly integrated 4 translational themes that include both didactic lectures and hands-on rotations
among the themes; (ii) inclusion of both Ph.D postdocs and MD fellows to promote both bench-to-bedside and
bedside-to-benchtop translational cancer research; (iii) an individualized mentor team consisting of both Ph.D
and MD faculty; (iv) boot camp for clinical trial preparation for trainees (v) support from Disease Oriented
Teams (DOTs) from WFBCCC; (vi) Transition to Independence (TTI) program to support trainees to become
independent through preparation for K-type applications; and (vii) Broad-base career opportunities and
development plans such as Ph.D/MBA for graduate students. Therefore, through this training program, Ph.D
fellows/students will learn how they can bring basic science knowledge into bedside, while MD fellows will have
a deeper understanding of translational, hypothesis-driven research.
总结
癌症是美国第二大死亡原因,许多挑战仍然存在,以发现新的,
更有效的方法来治愈这种毁灭性的疾病,这需要大力翻译基本的
科学知识走进诊所为了实现这一目标,并进一步促进转化癌症研究,
必须建立一个可持续的计划,以培训和教育下一代科学家,
临床医生,谁必须有广泛的知识和沟通能力,并与同事在这两个
领域的转化肿瘤学培训计划(TOTP)的目标是确保下一个
一代癌症研究人员配备了工具和知识,使他们能够
将实验室发现带入临床试验,反之亦然。这个项目的研究员和学生
将接受四个不同但高度集成的主题的独特培训:临床前建模(PCM);癌症
图像引导(CIG);癌症生物验证(CBV);和临床翻译(CLT)。PCM专注于分析
使用各种临床前模型研究肿瘤进展中涉及的通路和信号传导,
潜在的治疗靶点和生物标志物。CIG提供最先进的图像引导诊断培训
方法和纳米技术为基础的药物输送系统。CBV的学员将学习最新的
多组学环境中的生物信息学技能,以研究和分析大型队列患者数据库。
CLT的指导者有丰富的临床试验经验,他们提供了如何翻译的指导
基础知识应用到临床试验中。受训人员将在第一年轮流参加四个主题中的三个主题
同时接受四个主题的教学讲座。他们还将组建一个由两人组成的指导小组,
博士和MD教师。该T32计划的大多数导师都在血液学/肿瘤学,
癌症生物学系。这种结构融合了强大的临床和基础科学实体在唤醒
Forest Baptist Comprehensive Cancer Center(WFBCCC)然而,这个培训项目是多学科的
总共有十一个部门的老师。该计划是独特的许多创新的培训
工具:(i)高度整合的4个翻译主题,包括教学讲座和动手旋转
(二)包括博士博士后和医学博士研究员,以促进从临床到临床的研究,
从床边到台式转化癌症研究;(iii)由博士和博士组成的个性化导师团队
(iv)为受训人员提供临床试验准备的靴子训练营;(v)由疾病导向
(六)向独立过渡方案,以支持受训人员成为
通过准备K类申请而独立;和(七)基础广泛的职业机会,
研究生的博士/MBA等发展计划。因此,通过这个培训项目,博士
研究员/学生将学习如何将基础科学知识带到床边,而MD研究员将有
更深入地理解翻译,假设驱动的研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Timothy Sebastian Pardee其他文献
Timothy Sebastian Pardee的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Timothy Sebastian Pardee', 18)}}的其他基金
Determining the Role of Metabolism in Resistance in Acute Myeloid Leukemia
确定代谢在急性髓系白血病耐药中的作用
- 批准号:
9267416 - 财政年份:2016
- 资助金额:
$ 32.01万 - 项目类别:
Determining the Role of Metabolism in Resistance in Acute Myeloid Leukemia
确定代谢在急性髓系白血病耐药中的作用
- 批准号:
9913481 - 财政年份:2016
- 资助金额:
$ 32.01万 - 项目类别:
Determining the Role of Metabolism in Resistance in Acute Myeloid Leukemia
确定代谢在急性髓系白血病耐药中的作用
- 批准号:
9053051 - 财政年份:2016
- 资助金额:
$ 32.01万 - 项目类别:
Metabolic contribution to cell viability and therapy resistance in the acute
急性疾病中代谢对细胞活力和治疗耐药性的贡献
- 批准号:
8354423 - 财政年份:2012
- 资助金额:
$ 32.01万 - 项目类别:
Metabolic contribution to cell viability and therapy resistance in the acute
急性疾病中代谢对细胞活力和治疗耐药性的贡献
- 批准号:
8507659 - 财政年份:2012
- 资助金额:
$ 32.01万 - 项目类别:
Metabolic contribution to cell viability and therapy resistance in the acute
急性疾病中代谢对细胞活力和治疗耐药性的贡献
- 批准号:
8868066 - 财政年份:2012
- 资助金额:
$ 32.01万 - 项目类别:
Metabolic contribution to cell viability and therapy resistance in the acute
急性疾病中代谢对细胞活力和治疗耐药性的贡献
- 批准号:
8685202 - 财政年份:2012
- 资助金额:
$ 32.01万 - 项目类别:
相似海外基金
K12 Training for Clinical and Translational Oncology Researchers
临床和转化肿瘤学研究人员的 K12 培训
- 批准号:
10647170 - 财政年份:2023
- 资助金额:
$ 32.01万 - 项目类别:
UNC Integrated Translational Oncology Program (UNC-iTOP)
北卡罗来纳大学综合转化肿瘤学项目 (UNC-iTOP)
- 批准号:
10229476 - 财政年份:2019
- 资助金额:
$ 32.01万 - 项目类别:
UNC Integrated Translational Oncology Program (UNC-iTOP)
北卡罗来纳大学综合转化肿瘤学项目 (UNC-iTOP)
- 批准号:
10468679 - 财政年份:2019
- 资助金额:
$ 32.01万 - 项目类别:
UNC Integrated Translational Oncology Program (UNC-iTOP)
北卡罗来纳大学综合转化肿瘤学项目 (UNC-iTOP)
- 批准号:
10021631 - 财政年份:2019
- 资助金额:
$ 32.01万 - 项目类别:
Research Training Program in Basic and Translational Oncology
基础和转化肿瘤学研究培训计划
- 批准号:
8667643 - 财政年份:2014
- 资助金额:
$ 32.01万 - 项目类别:
Research Training Program in Basic and Translational Oncology
基础和转化肿瘤学研究培训计划
- 批准号:
8904635 - 财政年份:2014
- 资助金额:
$ 32.01万 - 项目类别: